This Promising GLP-1 Drug Could Renew Novo Nordisk Hope
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
Which Passive Funds Are Best For Retirement 2024 highlights top low-cost, diversified options that fit long-term retirement goals.
24,389 articlesNovo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
EUFN’s payouts face structural risk amid regulator changes and currency swings, threatening steady income for U.S.-ba...
Wintermute is stepping into the prediction-market arena by supplying liquidity on Kalshi and Polymarket, aiming to li...
Oil prices are falling, delivering relief to some budgets, but the Fed's decision to hold rates could keep mortgage c...
Costco stock has flashed sell-side headlines and uncertain momentum. This guide breaks down what a dip means for COST...
As companies report, global grow 2026 earnings becomes a key lens on global demand, margins, and cash flow. This guid...
Western Midstream Partners raised its quarterly distribution to $0.93 per unit, pushing the annualized payout to $3.7...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....
Anthropic, the Claude-maker, confidentially files to go public, igniting talk of a potential trillion-dollar valuatio...
When a high-profile artist hits legal trouble, the financial ripple effects can be wide. This article looks at how ba...
Morgan Stanley reveals a sharper cost curve for AI data centers, suggesting only a few players can fund the next wave...
IonQ posted quarterly results that beat expectations, triggering a notable after-hours rally. Analysts warn the stock...